Yahav Achim Ve Achayot Provident Funds Management CO Ltd. Chemomab Therapeutics Ltd. Call Options Transaction History
Yahav Achim Ve Achayot Provident Funds Management CO Ltd.
- $52.5 Million
- Q2 2024
Call Options
0 transactions
Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
---|
Others Institutions Holding CMMB
# of Institutions
17Shares Held
2.68MCall Options Held
0Put Options Held
0-
Orbimed Advisors LLC San Diego, CA2.24MShares$3.45 Million0.05% of portfolio
-
Ikarian Capital, LLC Dallas, TX213KShares$328,6230.08% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il62.4KShares$96,0990.0% of portfolio
-
Kestra Private Wealth Services, LLC31.2KShares$48,1110.0% of portfolio
-
Boothbay Fund Management, LLC New York, NY26.5KShares$40,8540.0% of portfolio
About Chemomab Therapeutics Ltd.
- Ticker CMMB
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 11,431,700
- Market Cap $17.6M
- Description
- Chemomab Therapeutics Ltd., a clinical-stage biotech company, discovers and develops therapeutics for the treatment of inflammation and fibrosis. The company's lead clinical product candidate is CM-101, a humanized monoclonal antibody that hinders the basic function of soluble chemokine CCL24 for the treatment of primary sclerosing cholangitis (...